1. Automatic subtyping of Diffuse Large B-cell Lymphomas (DLBCL): Raman-based genetic and metabolic classification
   Patrycja Dawiec et al, 2024, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy CrossRef
2. Artificial Intelligence and Digital Microscopy Applications in Diagnostic Hematopathology
   Hanadi El El Achi et al, 2020, Cancers CrossRef
3. Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy
   Jung Hyun Her et al, 2022, Cancer Immunology, Immunotherapy CrossRef
4. Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma
   Maria Patra-Kneuer et al, 2023, Frontiers in Immunology CrossRef
5. The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified
   Teja Cas Slak et al, 2024, Radiology and Oncology CrossRef
6. Correlation between red blood cell distribution width/platelet count and prognosis of newly diagnosed diffuse large B-cell lymphoma
   Xiaobo Liu et al, 2023, Blood Research CrossRef
7. CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review
   Gorana Gasljevic et al, 2023, Radiology and Oncology CrossRef